China Merchants Securities board approves HK$9bn capital injection for subsidiary

China Merchants Securities Co., Ltd. announced on December 8, 2025, that its board of directors unanimously approved a proposal for its subsidiary, China Merchants Securities (HK) Co., Ltd., to undertake a phased capital increase totaling no more than HK$9 billion into its wholly-owned subsidiaries.

The initial phase of this capital increase will target China Merchants Securities (Hong Kong) Co., Ltd., with an injection not exceeding HK$4 billion. The board further authorized China Merchants Securities (HK) Co., Ltd.'s board of directors to make decisions regarding subsequent phased capital increases and to handle all related matters based on actual circumstances.

All 14 directors present at the meeting voted in favor of the resolution regarding the capital increase, with no opposing votes or abstentions. The meeting, convened by chairman Huo Da, also included a resolution concerning the amendment of the "China Merchants Securities Co., Ltd. Managerial Level Staff Appointment Agreement," which was also unanimously approved.